A Socioethical View of Bioprinting Human Organs and Tissues Niki Vermeulen,1 Gill Haddow,1 Tirion Seymour,1 Alan Faulkner-Jones,2 Wenmiao Shu2

Total Page:16

File Type:pdf, Size:1020Kb

A Socioethical View of Bioprinting Human Organs and Tissues Niki Vermeulen,1 Gill Haddow,1 Tirion Seymour,1 Alan Faulkner-Jones,2 Wenmiao Shu2 Global medical ethics J Med Ethics: first published as 10.1136/medethics-2015-103347 on 20 March 2017. Downloaded from PAPER 3D bioprint me: a socioethical view of bioprinting human organs and tissues Niki Vermeulen,1 Gill Haddow,1 Tirion Seymour,1 Alan Faulkner-Jones,2 Wenmiao Shu2 ► Additional material is ABSTRACT induced pluripotent stem cells (iPSCs)) to print 3D published online only. To view In this article, we review the extant social science and constructs composed of living organic materials. please visit the journal online (http:// dx. doi. org/ 10. 1136/ ethical literature on three-dimensional (3D) bioprinting. These new forms of printing, should they be rea- medethics- 2015- 103347). 3D bioprinting has the potential to be a ‘game-changer’, lised, will, it is argued, have the same revolutionary printing human organs on demand, no longer and democratising effect as book printing in their 1Department of Science, necessitating the need for living or deceased human applicability to regenerative medicine and industry. Technology and Innovation donation or animal transplantation. Although the Individually designed biological structures or body Studies, University of Edinburgh, Edinburgh, UK technology is not yet at the level required to bioprint an parts will become as available as text in modern lit- 2Department of Biomedical entire organ, 3D bioprinting may have a variety of other erate societies. Engineering, University of mid-term and short-term benefits that also have positive There are obvious links drawn between 21st Strathclyde, Glasgow, UK ethical consequences, for example, creating alternatives century 3D bioprinting and the development of the to animal testing, filling a therapeutic need for minors 15th century printing press in terms of process as Correspondence to and avoiding species boundary crossing. Despite a lack well as similarities in the nascent development Dr Niki Vermeulen, Department of Science, Technology and of current socioethical engagement with the stages regarding the effect of resources and access Innovation Studies, University consequences of the technology, we outline what we for both printing technologies. of Edinburgh, Old Surgeons’ see as some preliminary practical, ethical and regulatory Long-term 3D bioprinting has the potential to be Hall, High School Yards, issues that need tackling. These relate to managing a ‘game-changer’, providing an alternative source Edinburgh EH1 1LZ, UK; of organs no longer necessitating the need for niki. vermeulen@ ed. ac. uk public expectations and the continuing reliance on technoscientific solutions to diseases that affect high- living or deceased human donation as human Received 30 December 2015 income countries. Avoiding prescribing a course of action organs would be printed on demand. Nonetheless, Revised 6 February 2017 for the way forward in terms of research agendas, we do there are key differences between printing and 3D Accepted 13 February 2017 briefly outline one possible ethical framework bioprinting. The latter is distinctive in terms of the Published Online First ‘ ’ 20 March 2017 Responsible Research Innovation as an oversight model technological process of printing, the organic pro- should 3D bioprinting promises are ever realised. 3D ducts that are involved, the therapeutic purpose bioprinting has a lot to offer in the course of time and, finally, in terms of placing the printed organ should it move beyond a conceptual therapy, but is an within a human body. The technology is not yet at http://jme.bmj.com/ area that requires ethical oversight and regulation and the level required to bioprint an entire organ. A debate, in the here and now. The purpose of this article realistic and short-term goal is for 3D bioprinting is to begin that discussion. to create alternatives to animal testing. For example, drug testing can be accomplished via bio- printed structures embedded within lab-on-a-chip BACKGROUND: ‘GROW YOUR OWN ORGANS’ devices and even improved by the dramatic increase 4–6 Recent media headlines suggest that scientists will in throughput the technology enables. on September 27, 2021 by guest. Protected copyright. in the future have the ability to create or ‘biofabri- Furthermore, a mid-term gain still to be realised cate’ personalised organs such as livers and hearts however, relates to the creation of tissue compo- through a process known as three-dimensional (3D) nents such as human heart valves, especially for – bioprinting.1 3 This is the biological variant of the younger members of the population (eg, paediatric recent trend towards 3D printing; small-scale patients) who suffer specific problems with current manufacturing of computer-designed forms bioprosthetic or mechanical heart valve (MHV) through laying down successive layers of material options. The required tissue components are until the entire object is created. This development created from the patient’s own cells (thus reducing draws on longstanding printing technology, which the risk of rejection) and the geometry (size and after the invention of the printing press in the 15th shape) of the components can be customised to century made books, and thereby knowledge, match perfectly with the patient’s requirements. widely available and affordable. Later in the 20th Unlike mechanical implants, such engineered tissue century with the development of the photocopier components that are 3D bioprinted have the ability and inkjet printers, the hardware component was to grow with the patient, eliminating the need for set. While 3D printing is working with inorganic further operations to replace components which materials, the intention of bioprinting is to work are no longer suitable.7 To cite: Vermeulen N, with organic materials (including living cells) to Given the promise of the technology to solve Haddow G, Seymour T, et al. create structures approximating body parts. entrenched ethical issues relating to supply and J Med Ethics Specialised bioprinters use biological inks (bioinks demand of human or non-human animal trans- 2017;43:618–624. —such as differentiated, human embryonic or plants, a thorough review of any specific 618 Vermeulen N, et al. J Med Ethics 2017;43:618–624. doi:10.1136/medethics-2015-103347 Global medical ethics J Med Ethics: first published as 10.1136/medethics-2015-103347 on 20 March 2017. Downloaded from socioethical pitfalls is instructive. In order to scope the existing After outlining extant literature and given we found little ethical social science literature in the field of bioprinting, literature or social commentary from an arts, social science and humanities searches of articles and book references were undertaken on the perspective, we offer a comparative ethical analysis weighing up databases PubMed, Web of Science and JSTOR in March and a few of the benefits and challenges 3D bioprinting may cause April 2016, and undertaken again in June 2016 in order to iden- should its promise be realised. There are different frameworks tify any extra articles (figure 1). In addition to this, the Institute for engaging with social science and ethical aspects of new of Physics journal Biofabrication was searched as a leading technologies and we outline and discuss whether Responsible journal in this area of biofabrication and bioprinting. This Research Innovation (RRI), currently favoured, may be a way to review exercise found that with only a few notable exceptions deal with and reflect on 3D bioprinting, especially around inter- – from the areas of law or social sciences,8 15 the current literature disciplinary ethics. 3D bioprinting may have a lot to offer in the on bioprinting specifically (rather than traditional 3D printing) course of time, but as an area, it needs ethical oversight and is located entirely within the biological sciences and medical regulation as well as debate. A debate we hope to begin. sciences. Much of the medical and scientific literature, however, does focus on some social aspect of the technology within dis- 3D BIOPRINTING AND BIOFABRICATION cussion to some extent. This allows analysis of both what is 3D printing is undoubtedly proven successful and 3D printers fi already being highlighted within scienti c articles, and allows are now widely used and commercially available. Bioprinting as a fi the identi cation of areas where social science research might particular area regularly discussed in both academic literature fi build on existing themes or ll gaps in understanding. The latter and the media in connection alongside 3D printing techniques we will address through offering both positive and negative ana- that use non-biological materials (eg, plastics, metals, fabrics or lysis of the socioethical challenges that might lie ahead. ceramics). 3D printing of objects has rapidly developed from Although bioprinting can avoid ethical dilemmas associated being a niche and expensive development on two-dimensional with xenotransplantation and clinical organ transplantation, it is (2D) printing technology in the 1980s to now being an extremely not without its own challenges, practical, ethical and regulatory, rapidly developing industry with ever-increasing applications. which we will need to address. These relate to managing public Bioprinting is a far more complex matter, which is explored ’ expectations and the ethics of biomedicine s continuing reliance in the emerging field of biofabrication. Although the terms bio- fi on costly technoscienti c solutions. For example, the expense of printing and biofabrication are often used interchangeably
Recommended publications
  • A Brief Comparison Between Available Bio-Printing Methods
    GREAT LAKES BIOMEDICAL CONFERENCE 1 A Brief Comparison Between Available Bio-printing Methods Ali Bakhshinejad,Roshan M D’Souza Abstract—The scarcity of organs for transplant has led to large waiting lists of very sick patients. In drug development, the time required for human trials greatly increases the time to market. Drug companies are searching for alternative environments where the in − vivo conditions can be closely replicated. Both these problems could be addressed by manufacturing artificial human tissue. Recently, researchers in tissue engineering have developed tissue generation methods based on 3-D printing to fabricate artificial human tissue. Broadly, these methods could be classified as laser- assisted and laser free. The former have very fine spatial resolutions (10s of µm) but suffer from slow speed ( < 102 drops per second). The later have lower spatial resolutions (100s of µ m) but are very fast (up to 5 × 103 drops per second). In this paper we review state-of-the-art methods in each of these classes and provide a comparison based on reported resolution, printing speed, cell density and cell viability. Keywords—Bio-printing, Tissue Engineering. ✦ 1 INTRODUCTION colonization process, the scaffold resolves into NTRODUCTION of the first 3D printing the systems. Scaffold material porosity is de- I method by Charles W. Hull in 1986 [1], signed in a way to enable inward diffusion changed the world of manufacturing. Com- of nutrients, oxygen and outward diffusion of plex shapes that previously could not be man- waste materials from the living cells. Scaffold- ufactured without expensive tooling such as based methods can further be categorized into mutli-part molds could be manufactured with two main approaches: first approach is when ease through layered deposition of material.
    [Show full text]
  • Artificial Organ Introduction an Artificial Organ Is a Man-Made
    Artificial Organ Introduction An artificial organ is a man-made device that is implanted or integrated into a human body to replace a natural organ or restoring a specific function so the patient may return to as normal a life as possible. They can be used both for functions that are essential to life and also for purposes that are not related to survival but do improve a person's quality of life. The organs that can be replaced artificially are quite numerous (including the ears, ovaries, and even the heart and brain), eg. artificial heart, pacemaker, artificial kidney machine, heart-lung machine, etc. Perhaps the most common manifestation of an artificial organ is hearing aids that are used to improve a person's ability to hear and distinguish sounds. The replaced function doesn't necessarily have to be related to life support, but the ultimate goal of artificial organ research and development is fully functional created organs that can be integrated into the body which fully replaces the natural organ and remains functional for a lifetime. Many steps have been taken towards this goal, and it is very likely that the field will continue to change and develop. The reasons to construct and install an artificial organ might include: Life support to prevent imminent death while awaiting a transplant (e.g. artificial heart) Dramatic improvement of the patient's ability for self care (e.g. artificial limb) Improvement of the patient's ability to interact socially (e.g. cochlear implant) Cosmetic restoration after cancer surgery or accident Previously, an artificial organ would be created completely out of synthetic material, such as plastics or metals.
    [Show full text]
  • Bioprinting: a Further Step to Effective Regenerative Medicine and Tissue Engineering
    e in G net ts ic n E e n g m i e n c e e n r a i v n Conese, Adv Genet Eng 2014, 2:3 d g A Advancements in Genetic Engineering ISSN: 2169-0111 DOI: 10.4172/2169-0111.1000e112 Editorial Open Access Bioprinting: A Further Step to Effective Regenerative Medicine and Tissue Engineering Massimo Conese* Department of Medical and Surgical Sciences, University of Foggia, Foggia 71122, Italy *Corresponding author: Massimo Conese, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy, Tel.: +39-0881-588019; E-mail: [email protected] Rec date: Aug 11, 2014, Acc date: Aug 12, 2014, Pub date: Aug 16, 2014 Copyright: © 2014 Conese M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Keywords: Bio-fabrication Cell printing; Composite organ; major hurdles in transplantation, namely the shortage of organs and Hydrogel; Organ printing; Stem cell therapy; Three-dimensional the toxicity deriving from lifelong immunosuppression. Thus, major printing progress in regenerative therapies will require cell-based products made of many cell types to recapitulate organ metabolic function, and Editorial structure to support mechanical function. Recently, this has been partially accomplished by the generation of functional Liver Buds Regenerative medicine is a multidisciplinary field that aims to (LBs) from iPSCs [9]. Hepatic endoderm cells from human iPSCs replace or regenerate human cells, tissues, or organs in order to restore (iPSC-HEs) were cultivated with stromal cell populations, Human or establish normal function.
    [Show full text]
  • Organ Printing As an Information Technology
    Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 110 ( 2015 ) 151 – 158 4th International Conference on Tissue Engineering, ICTE2015 Organ Printing as an Information Technology Rodrigo A. Rezendea, Vladimir Kasyanovb, Vladimir Mironova,c, Jorge Vicente Lopes da Silvaa aDivision of 3D Technologies, Renato Archer Center for Information Technology, Campinas, SP, Brazil bRiga Stradins University and Riga Technological University, Riga, Latvia, European Union cDIMAV, InMetro, Xerém, Duque de Caxias, RJ, Brazil Abstract Organ printing is defined as a layer by layer additive robotic computer-aided biofabrication of functional 3D organ constructs with using self-assembling tissue spheroids according to digital model. Information technology and computer-aided design softwares are instrumental in the transformation of virtual 3D bioimaging information about human tissue and organs into living biological reality during 3D bioprinting. Information technology enables design blueprints for bioprinting of human organs as well as predictive computer simulation both printing and post-printing processes. 3D bioprinting is now considered as an emerging information technology and the effective application of existing information technology tools and development of new technological platforms such as human tissue and organ informatics, design automation, virtual human organs, virtual organ biofabrication line, mathematical modeling and predictive computer simulations of bioprinted tissue fusion and maturation is an important technological imperative for advancing organ bioprinting. © 2015 The The Authors. Authors. Published Published by byElsevier Elsevier Ltd. Ltd.This is an open access article under the CC BY-NC-ND license (Peer-reviewhttp://creativecommons.org/licenses/by-nc-nd/4.0/ under responsibility of IDMEC-IST.). Peer-review under responsibility of IDMEC-IST Keywords: 3D bioprinting; information technology; computer-aided design; computer simulation; organ informatics; organ printing 1.
    [Show full text]
  • Bioprinting Towards Organ Fabrication: Challenges and Future Trends Ibrahim Ozbolat and Yin Yu
    This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. TBME-01840-2012 1 Bioprinting towards Organ Fabrication: Challenges and Future Trends Ibrahim Ozbolat and Yin Yu proliferation, and direct cell differentiation toward certain Abstract— Tissue engineering has been a promising field of lineages. Although significant success has been achieved in the research, offering hope for bridging the gap between organ past decades both in research and clinical applications [7], it is shortage and transplantation needs. However, building three- obvious that complex 3D organs require more precise multi- dimensional (3D) vascularized organs remains the main technological barrier to be overcome. Organ printing, which is cellular structures with vascular network integration, which defined as computer-aided additive biofabrication of 3D cellular cannot be fulfilled by traditional methods. tissue constructs, has shed light on advancing this field into a new era. Organ printing takes advantage of rapid prototyping (RP) technology to print cells, biomaterials, and cell-laden biomaterials individually or in tandem, layer by layer, directly creating 3D tissue-like structures. Here, we overview RP-based bioprinting approaches and discuss the current challenges and trends towards fabricating living organs for transplant in the near future. Index Terms— Bioadditive manufacturing, bioprinting, organ fabrication, tissue engineering I. INTRODUCTION RGAN shortage has become more problematic in spite of O an increase in willing donors. From July 2000 to July 2001, for example, approximately 80,000 people in the United States awaited an organ transplant, with less than a third receiving it [1].
    [Show full text]
  • Artificial Organs
    Schaub 5:00 L19 Disclaimer: This paper partially fulfills a writing requirement for first year (freshman) engineering students at the University of Pittsburgh Swanson School of Engineering. This paper is a student paper, not a professional paper. This paper is based on publicly available information and may not provide complete analyses of all relevant data. If this paper is used for any purpose other than this author’s partial fulfillment of a writing requirement for first year (freshman) engineering students at the University of Pittsburgh Swanson School of Engineering, users are doing so at their own risk. INNOVATIONS IN BIOENGINEERING: ARTIFICIAL ORGANS Jason Zheng ([email protected]) WHAT’S AHEAD? failure will only become more common. For example, every single day, roughly 20 individuals will lose their With thorough research and thoughtful lives waiting for a transplant [2]. Additionally, only consideration, I’ve decided that bioengineering is the about half of US adults are signed up as organ donors right career path for me. I find bioengineering so [2]. A single individual can donate multiple organs for intriguing because it is a constant growing field with these patients, but many refuse to do so. The lack of research opportunities available in areas such as organ donors has caused many preventable deaths, and bioinstrumentation, biomechanics, bioimaging, and medical researchers and professionals are trying their regenerative medicine. In order to advance healthcare, best to come up with solutions to this problem. In hopes bioengineers must make use of their scientific of saving these lives, researchers have turned to the knowledge and ingenuity in order to develop solutions laboratory in search for these extra organs.
    [Show full text]
  • An Integrated Approach to Three-Dimensional Bioprinting at Subfreezing Temperatures
    An Integrated Approach to Three-Dimensional Bioprinting at Subfreezing Temperatures By Gideon C Ukpai A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Engineering - Mechanical Engineering in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Boris Rubinsky, Chair Professor Chris Dames Professor Kevin Healy Summer 2020 An Integrated Approach to Three-Dimensional Bioprinting at Subfreezing Temperatures Copyright 2020 By Gideon Ukpai 1 Abstract An Integrated Approach to Three-Dimensional Bioprinting at Subfreezing Temperatures by Gideon Ukpai Doctor of Philosophy in Mechanical Engineering University of California, Berkeley Professor Boris Rubinsky, Chair There are over 100,000 patients on the US transplant list alone, and millions more needing transplants globally. Many of these transplant patients have little hope of getting a replacement organ in time to ensure survival. On-demand fabrication of organs and tissues using tissue engineering could provide a solution and save the lives of millions of transplant patients and patients with end-stage organ failure. A major component of fabricating these artificial tissues and organs is the construction of a scaffold, often with the cells incorporated, that simulates the appropriate tissue environment and guides the formation of complex tissue structures. Three- dimensional (3D) bioprinting has emerged as the most promising approach for developing these scaffold constructs, but despite significant advances, the technique faces various challenges. Some factors that have thus far limited the production of clinically relevant constructs include, insufficient mechanical properties for fabrication of full-scale organs, unsustainably long print times, and poor survival of the biological matter during and after printing due to lack of vascularization.
    [Show full text]
  • Organ-On-Chip in Development: Towards a Roadmap for Organs-On-Chip Doi:10.14573/Altex.1908271
    Meeting Report Organ-on-Chip in Development: Towards a Roadmap for Organs-on-Chip doi:10.14573/altex.1908271 1 Introduction other hazard risks of various substances under increasingly strin- gent regulatory requirements (Marx et al., 2016). Organ-on-Chip is considered a potentially game-changing tech- Organ-on-Chip (OoC) is increasingly regarded as a potential- nology born from the convergence of tissue engineering and mi- ly game-changing technology for these problems (Bahinski et al., crofluidic technology. Organ-on-Chip devices (OoCs) are ex- 2015) and able to meet the needs of different stakeholders (Mid- pected to offer effective solutions to persisting problems in drug delkamp et al., 2016). In spite of its promise (Zhang and Radis- development and personalized disease treatments. This report sur- ic, 2017), pharma has nevertheless remained cautious to invest veys the current landscape in research, development, application, in this new technology, presently awaiting evidence of its add- and market opportunities for OoCs towards establishing a glob- ed cost-benefit value and whether it could represent a feasible al and multi-stakeholder OoC ecosystem. Based on panel discus- route to precision medicine and improved patient stratification. It sions held at the Vision Workshop (Stuttgart, 23 May 2018) orga- is thus necessary to bridge the gap between the potential of OoC nized by the EU ORCHID consortium, as well as on additional systems and their worldwide acceptance. Defining the putative bibliometric study, market analysis, and expert interviews con- benefits of OoCs and how these can be proven and achieved is the ducted within the EU ORCHID project, we outline perceived un- preamble for an OoC roadmap – which is one of the aims of the met needs, key challenges, barriers, and perspectives of the field.
    [Show full text]
  • As Tudy of Artificial Organs And
    International Journal of Advances in Materials Science and Engineering (IJAMSE) Vol.1, No.1, October 2012 BIOMEDICINE AND BIOMATERIAL: A STUDY OF ARTIFICIAL ORGANS AND XENOTRANSPLANTATION So Yeon Yoon The Putney School [email protected] ABSTRACT Organ demand is outpacing the supply of donated organs. In order to solve this problem, biomedicine is a rising trend in the science world. Biomedicine is a branch of medical science that applies biologic and other natural-science principles to clinical practice such as developing artificial organs. As biomedicine progressed artificial organs and xenotransplantation, which is transplantation of organs from one species to another, advanced. Biomedicine is hope to lots of people who are suffering from organ failure. However, rejection of the organs by the body and ethical problems are the barriers of this area of biomedicine development. KEYWORDS Artificial organs, Xenotransplantation, Biomaterial Organ demand is outpacing the supply of donated organs. In order to solve this problem, biomedicine is a rising trend in the science world. Biomedicine is a branch of medical science that applies biologic and other natural-science principles to clinical practice such as developing artificial organs. As biomedicine progressed artificial organs and xenotransplantation, which is transplantation of organs from one species to another, advanced. Biomedicine is hope to lots of people who are suffering from organ failure. However, rejection of the organs by the body and ethical problems are the barriers of this area of biomedicine development. There are a lot of patients who are waiting for organ transplantation but not everyone can get organ transplanted because the supply of organs is not on-demand.
    [Show full text]
  • CHEM-E8135 Microfluidics and Biomems Organs-On-Chips
    CHEM-E8135 Microfluidics and BioMEMS Organs-on-Chips 27.2.2019 Ville Jokinen Intended learning outcomes The student understand the definition, concept and purpose of organ-on-chips. The student can name several types of organ on chips and describe their basic idea. The student knows the basics of organ-on-chip design Outline 1. Introduction 2. Lung-on-a-chip -we learn the concept of mimicing a feature with this example 3. CNS, Kidney and Gut models -short overview of other types to see similarities and differences 4. A task for students, create definition for OoC -What is organ-on-a-chip exactly? 5. A brief overview of materials, cell types, fabrication, commercialization Organ-on-chip, what are they? • Miniaturized, microchip based models of organs • Current status: proof-of-concept studies, basic biomedical research • In future, a solution to rising costs of pharmaceutical development? Why organs-on-a-chip? • Basic research: Possibility for experimentation at a level intermediate to cell culture models and animal models. • Pharmaceutical industry: Need for more efficient screening • Animal models: + Direct experimentation on in vivo conditions - Ethical issues, time and cost. Biological complexity can be overwhelming. • Cell culture models: + Simplicity - Lack of architecture - Far removed from in vivo conditions • Organ-on-a-chip models: + A middle ground between cell culture and animal models? + Can utilize human cells also - Not a mature field yet - Largely undemonstrated for actual biological and biomedical research. Modeling of organ functions • Organ-on-a-chip should reproduce, mimic or approximate some aspect of the target organ that is missing on a petri dish.
    [Show full text]
  • Benefits and Limitations of Three-Dimensional Printing Technology for Ecological Research
    Behm et al. BMC Ecol (2018) 18:32 https://doi.org/10.1186/s12898-018-0190-z BMC Ecology METHODOLOGY ARTICLE Open Access Benefts and limitations of three‑dimensional printing technology for ecological research Jocelyn E. Behm1,2* , Brenna R. Waite1,3, S. Tonia Hsieh4 and Matthew R. Helmus1 Abstract Background: Ecological research often involves sampling and manipulating non-model organisms that reside in heterogeneous environments. As such, ecologists often adapt techniques and ideas from industry and other scientifc felds to design and build equipment, tools, and experimental contraptions custom-made for the ecological systems under study. Three-dimensional (3D) printing provides a way to rapidly produce identical and novel objects that could be used in ecological studies, yet ecologists have been slow to adopt this new technology. Here, we provide ecolo- gists with an introduction to 3D printing. Results: First, we give an overview of the ecological research areas in which 3D printing is predicted to be the most impactful and review current studies that have already used 3D printed objects. We then outline a methodological workfow for integrating 3D printing into an ecological research program and give a detailed example of a success- ful implementation of our 3D printing workfow for 3D printed models of the brown anole, Anolis sagrei, for a feld predation study. After testing two print media in the feld, we show that the models printed from the less expensive and more sustainable material (blend of 70% plastic and 30% recycled wood fber) were just as durable and had equal predator attack rates as the more expensive material (100% virgin plastic).
    [Show full text]
  • Moving Towards Functional Renal Bioprinting
    Moving Towards Functional Renal Bioprinting Emily Thomas# and Evan Mettenbrink# Stephenson School of Biomedical Engineering, University of Oklahoma, Norman OK 73071 Abstract 3D bioprinting technologies are rapidly developing and provide a platform for manufacturing structures that mimic the in vivo environment. Recent research aims to produce 3D bioprinted structures that recapitulate both in vivo structure and functionality. Advancements in both producing high fidelity and functional structures pave the way for full organ bioprinting. Full organ bioprinting holds promise for patients facing renal diseases given both the limited availability of donor kidneys for transplantation which offers the highest quality of life for patients facing renal failure. While the generation of a fully functional bioprinted kidney is a long-term goal, the first step is generating bioprinted functional renal tissue. Functional bioprinted renal tissue may pave the way for full scale organ printing and may offer a more accurate in vitro model for testing the renal toxicity of newly developed therapeutics which holds promise given the limitations of current preclinical in vivo and in vitro models to accurately predict renal toxicity of newly developed therapeutics in humans. Recent work showcases advancements toward renal bioprinting and advancements in the field of bioprinting more broadly may provide opportunities for advancement in renal bioprinting. This review aims to cover recent advances in renal bioprinting and opportunities for innovation. The review seeks to address the mechanical, biological and translational aspects of bioprinting functional renal tissue through an overview of recent advancements (last 5 years) in developing bioinks, utilizing existing 3D bioprinting methods to produce high fidelity printed structures, supporting viability, cell adhesion, cell distribution, functionality and vascularization, and considering important translational aspects of renal bioprinting including larger-scale printing, clinical potential, and prospects towards whole organ generation.
    [Show full text]